Daily asthma drugs not essential

Baines, Emma
April 2005
GP: General Practitioner;4/15/2005, p2
The article informs that mild asthma may be controlled as effectively by short, intermittent courses of inhaled corticosteroids as by daily treatment. The study included 225 adults with persistent, mild asthma who did not smoke. Their FEV1 was at least 70 per cent of the predicted value and they responded to a methacholine 16mg challenge with a 20 per cent drop in FEV1. The patients were assigned to take 200mu g of budesonide twice daily, 20mg of zafirlukast twice daily or a placebo inhaler.


Related Articles

  • Analysis. Summerton, Nick // Update;5/19/2005, Vol. 70 Issue 5, p26 

    This article presents a study to find out whether intermittent as-needed corticosteroid treatment for mild persistent asthma equivalent to regular daily treatment. Treatment with daily or intermittent corticosteroid therapy in a six-centre randomised controlled trial was conducted. After...

  • Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. South, Mike // Internet Journal of Pediatrics & Neonatology;2005, Vol. 5 Issue 1, p23 

    This article focuses on a study that deals with an early intervention with budesonide in mild persistent asthma. A randomized, double-blind clinical trial in 7241 patients in 32 countries was conducted to assess the effects of budesonide in patients who had mild persistent asthma for less than 2...

  • Mild persistent asthma and inhaled corticosteroids: is daily therapy really necessary? Bauchner, Howard // Archives of Disease in Childhood;Oct2005, Vol. 90 Issue 10, p1094 

    This article cites a study on the treatment of mild persistent asthma, which was published in the May 6, 2005 issue of the "Journal Watch Pediatrics and Adolescent Medicine." In this double-blind trial, researchers randomized 225 adults with mild persistent asthma to receive twice-daily inhaled...

  • Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects. Harrison, T. W.; Wisniewski, A.; Honour, J.; Tattersfield, A. B. // Thorax;Mar2001, Vol. 56 Issue 3, p186 

    Background-The potential for long term adverse effects from inhaled corticosteroids relates to their systemic absorption, usually assessed from proxy markers in short term studies. When fiuticasone propionate and budesonide have been compared in this way the results have been inconsistent. To...

  • The use of corticosteroids in patients with COPD or asthma does not decrease lung squamous cell carcinoma. Zhi-Hong Jian; Jing-Yang Huang; Frank Cheau-Feng Lin; Oswald Ndi Nfor; Kai-Ming Jhang; Wen-Yuan Ku; Chien-Chang Ho; Chia-Chi Lung; Hui-Hsien Pan; Yu-Chiu Liang; Ming-Fang Wu; Yung-Po Liaw; Jian, Zhi-Hong; Huang, Jing-Yang; Lin, Frank Cheau-Feng; Nfor, Oswald Ndi; Jhang, Kai-Ming; Ku, Wen-Yuan; Ho, Chien-Chang; Lung, Chia-Chi // BMC Pulmonary Medicine;12/3/2015, Vol. 15, p1 

    Background: Asthma and COPD (chronic obstructive pulmonary disease) lead to persistent airway inflammation and are associated with lung cancer. The objective of the study was to assess the relationship between inhaled (ICS) and oral corticosteroid (OCS) use, and risk of lung...

  • Independent Nurse: Nitric oxide could guide asthma care.  // GP: General Practitioner;6/3/2005, p90 

    The article reports that measuring exhaled nitric oxide enables practitioners to reduce doses of inhaled corticosteroids without compromising asthma control. Researchers used exhaled nitric oxide measurements to guide asthma treatment in 46 patients. After 12 months the number of asthma...

  • Asthma meds: Getting to the right answer. Corjulo, Michael // Contemporary Pediatrics;Jul2007, Vol. 24 Issue 7, p87 

    The article offers tips about asthma medications from a medical professional. He states that when asking patients about their adherence to their medication regime, patients' answers can be too vague to be of any use. He offers that when he talks to an older child about the use of controller...

  • Beclazone Easi-Breathe.  // Royal Society of Medicine: Medicines;2002, p100 

    The article presents information on beclazone easi-breathe, a proprietary, prescription-only preparation of the corticosteroid beclometasone dipropionate. It can be used to prevent asthma attacks and is available in forms for aerosol inhalation with breath-actuated units.

  • Inhaled cortico-steroids and COPD exacerbations.  // Infectious Disease Alert;Apr2010 Primary Care, p8 

    The article discusses research done by R. Agarwal and colleagues on inhaled corticosteroids versus placebo for preventing chronic obstructive pulmonary disease (COPD) exacerbations, published in a 2010 issue of "Chest."


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics